Integral Derivatives’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-26,700
Closed -$1.52M 665
2017
Q4
$1.52M Sell
26,700
-33,500
-56% -$1.86M 0.03% 359
2017
Q3
$3.21M Buy
60,200
+32,300
+116% +$1.62M 0.06% 209
2017
Q2
$1.36M Buy
+27,900
New +$1.26M 0.03% 397
2017
Q1
Sell
-7,300
Closed -$280K 1123
2016
Q4
$280K Sell
7,300
-2,600
-26% -$103K 0.01% 898
2016
Q3
$419K Buy
9,900
+3,900
+65% +$167K 0.01% 687
2016
Q2
$236K Sell
6,000
-4,000
-40% -$159K 0.01% 802
2016
Q1
$418K Sell
10,000
-400
-4% -$15.8K 0.01% 562
2015
Q4
$467K Hold
10,400
0.01% 669
2015
Q3
$418K Sell
10,400
-4,200
-29% -$198K 0.01% 759
2015
Q2
$717K Buy
14,600
+4,200
+40% +$202K 0.02% 625
2015
Q1
$482K Sell
10,400
-24,600
-70% -$1.13M 0.01% 709
2014
Q4
$1.58M Buy
35,000
+25,000
+250% +$1.09M 0.03% 520
2014
Q3
$416K Buy
+10,000
New +$423K 0.01% 1022

Other funds holding ABT

Integral Derivatives's ABT Position: Q3 2017 in Review

Integral Derivatives sold out of Abbott (ABT) in Q3 2017, closing a stake of 4,519 shares — an estimated $227K sold.

Integral Derivatives first reported a position in ABT in Q4 2013 and held it in 4 quarters. The position peaked at $1.73M in Q4 2013. 1,597 funds tracked by Wall St. Rank hold ABT as of Q3 2017.

  • Integral Derivatives reported no remaining Abbott position as of Q3 2017 after selling out during the quarter.
  • Integral Derivatives sold 4,519 Abbott shares in Q3 2017, an estimated $227K.
  • Integral Derivatives first reported a position in Abbott in Q4 2013 and held it in 4 quarters.
  • Integral Derivatives's Abbott position peaked at $1.73M in Q4 2013.
  • 1,597 funds tracked by Wall St. Rank held Abbott as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.